Symbols / NVO $39.42 -2.57% Novo Nordisk A/S
NVO Chart
About
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Fundamentals
Scroll to Statements| Market Cap | 175.36B | Enterprise Value | 279.18B | Income | 102.43B | Sales | 309.06B | Book/sh | 6.87 | Cash/sh | 6.07 |
| Dividend Yield | 4.57% | Payout | 50.42% | Employees | 68794 | IPO | — | P/E | 10.92 | Forward P/E | 11.40 |
| PEG | 4.41 | P/S | 0.57 | P/B | 5.74 | P/C | — | EV/EBITDA | 1.82 | EV/Sales | 0.90 |
| Quick Ratio | 0.54 | Current Ratio | 0.80 | Debt/Eq | 67.49 | LT Debt/Eq | — | EPS (ttm) | 3.61 | EPS next Y | 3.46 |
| EPS Growth | -4.70% | Revenue Growth | -7.60% | Earnings | 2026-05-06 | ROA | 17.43% | ROE | 60.70% | ROIC | — |
| Gross Margin | 82.41% | Oper. Margin | 44.53% | Profit Margin | 33.14% | Shs Outstand | 3.36B | Shs Float | 3.19B | Short Float | 0.63% |
| Short Ratio | 1.04 | Short Interest | — | 52W High | 81.44 | 52W Low | 35.12 | Beta | 0.27 | Avg Volume | 22.15M |
| Volume | 25.09M | Target Price | $46.75 | Recom | Buy | Prev Close | $40.46 | Price | $39.42 | Change | -2.57% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-02 | down | Goldman Sachs | Buy → Neutral | $41 |
| 2026-02-24 | down | JP Morgan | Overweight → Neutral | — |
| 2026-01-09 | init | CICC | — → Outperform | $74 |
| 2025-12-08 | down | Argus Research | Buy → Hold | — |
| 2025-11-28 | main | Goldman Sachs | Buy → Buy | $54 |
| 2025-11-25 | main | BMO Capital | Market Perform → Market Perform | $46 |
| 2025-11-24 | down | HSBC | Buy → Hold | — |
| 2025-10-14 | main | BMO Capital | Market Perform → Market Perform | $55 |
| 2025-10-02 | up | HSBC | Hold → Buy | $70 |
| 2025-09-29 | down | Morgan Stanley | Equal-Weight → Underweight | $47 |
| 2025-09-17 | up | Berenberg | Hold → Buy | — |
| 2025-08-19 | main | TD Cowen | Buy → Buy | $70 |
| 2025-08-05 | down | UBS | Buy → Neutral | — |
| 2025-07-31 | down | HSBC | Buy → Hold | — |
| 2025-07-30 | down | Barclays | Overweight → Equal-Weight | — |
| 2025-06-18 | reit | TD Cowen | Buy → Buy | $105 |
| 2025-04-17 | down | BMO Capital | Outperform → Market Perform | $64 |
| 2025-01-08 | up | UBS | Sell → Buy | — |
| 2024-12-23 | main | BMO Capital | Outperform → Outperform | $105 |
| 2024-11-06 | reit | Cantor Fitzgerald | Overweight → Overweight | $160 |
News
RSS: Latest NVO news- Novo Nordisk: Is The GLP‑1 Golden Age Already Behind It? (NYSE:NVO) - Seeking Alpha Wed, 22 Apr 2026 10
- Novo Nordisk (NVO) slides as GLP-1 pricing and competition worries stay in focus - Quiver Quantitative ue, 21 Apr 2026 15
- Lilly and Novo Stocks Are Tumbling. How Amazon Is Shaking Up the GLP-1 Game. - Barron's ue, 21 Apr 2026 17
- Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance Fri, 17 Apr 2026 21
- Novo Nordisk Brings in OpenAI as NVO Stock Sits Near 52-Week Lows Amid Generic Pressure, Eli Lilly Competition - foreignpolicyjournal.com hu, 16 Apr 2026 21
- LLY, NVO Stocks Slide As Health Insurers Balk At Medicare Coverage For Obesity Drugs - Stocktwits ue, 21 Apr 2026 19
- Novo-Nordisk A/S (NVO) Stock Forum and Discussion - Moomoo Sat, 18 Apr 2026 19
- How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q1 Results? - TradingView Mon, 20 Apr 2026 14
- [6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC Filing - Form 6-K - Stock Titan Mon, 20 Apr 2026 13
- How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q1 Results? - Zacks Investment Research Mon, 20 Apr 2026 13
- Novo Nordisk A/S Stock (NVO) Moved Down by 3.60% on Apr 21: Facts Behind the Movement - TradingKey ue, 21 Apr 2026 17
- Agios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD Study - Yahoo Finance ue, 21 Apr 2026 13
- Novo Nordisk: I Admit That I Was Really Wrong (Downgrade) (NYSE:NVO) - Seeking Alpha Wed, 01 Apr 2026 07
- Novo Nordisk (NVO) Prepares for May 6 Earnings With Stock Price Near Multi-Year Lows - foreignpolicyjournal.com Sat, 18 Apr 2026 17
- Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up? - Yahoo Finance Fri, 20 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
309,064.00
+6.43%
|
290,403.00
+25.03%
|
232,261.00
+31.26%
|
176,954.00
|
| Operating Revenue |
|
729,423.00
+7.18%
|
680,563.00
+11.82%
|
608,645.00
+33.56%
|
455,692.00
|
| Cost Of Revenue |
|
58,788.00
+32.04%
|
44,522.00
+24.48%
|
35,765.00
+25.72%
|
28,448.00
|
| Reconciled Cost Of Revenue |
|
58,788.00
+32.04%
|
44,522.00
+24.48%
|
35,765.00
+25.72%
|
28,448.00
|
| Gross Profit |
|
250,276.00
+1.79%
|
245,881.00
+25.13%
|
196,496.00
+32.32%
|
148,506.00
|
| Operating Expense |
|
122,618.00
+4.32%
|
117,542.00
+25.15%
|
93,922.00
+27.44%
|
73,697.00
|
| Research And Development |
|
52,039.00
+8.27%
|
48,062.00
+48.14%
|
32,443.00
+34.91%
|
24,047.00
|
| Selling General And Administration |
|
70,279.00
+4.31%
|
67,377.00
+9.38%
|
61,598.00
+21.53%
|
50,684.00
|
| Selling And Marketing Expense |
|
64,310.00
+3.56%
|
62,101.00
+9.44%
|
56,743.00
+22.78%
|
46,217.00
|
| General And Administrative Expense |
|
5,969.00
+13.13%
|
5,276.00
+8.67%
|
4,855.00
+8.69%
|
4,467.00
|
| Other Gand A |
|
5,969.00
+13.13%
|
5,276.00
+8.67%
|
4,855.00
+8.69%
|
4,467.00
|
| Other Operating Expenses |
|
300.00
-85.73%
|
2,103.00
+1867.23%
|
-119.00
+88.49%
|
-1,034.00
|
| Total Expenses |
|
181,406.00
+11.93%
|
162,064.00
+24.97%
|
129,687.00
+26.96%
|
102,145.00
|
| Operating Income |
|
127,658.00
-0.53%
|
128,339.00
+25.12%
|
102,574.00
+37.11%
|
74,809.00
|
| Total Operating Income As Reported |
|
127,658.00
-0.53%
|
128,339.00
+25.12%
|
102,574.00
+37.11%
|
74,809.00
|
| EBITDA |
|
156,729.00
+5.94%
|
147,938.00
+29.06%
|
114,629.00
+49.25%
|
76,802.00
|
| Normalized EBITDA |
|
150,651.00
+1.12%
|
148,978.00
+31.91%
|
112,940.00
+37.66%
|
82,040.00
|
| Reconciled Depreciation |
|
21,982.00
+15.05%
|
19,107.00
+102.99%
|
9,413.00
+27.86%
|
7,362.00
|
| EBIT |
|
134,747.00
+4.59%
|
128,831.00
+22.44%
|
105,216.00
+51.52%
|
69,440.00
|
| Total Unusual Items |
|
6,078.00
+684.42%
|
-1,040.00
-161.57%
|
1,689.00
+132.25%
|
-5,238.00
|
| Total Unusual Items Excluding Goodwill |
|
6,078.00
+684.42%
|
-1,040.00
-161.57%
|
1,689.00
+132.25%
|
-5,238.00
|
| Net Income |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Pretax Income |
|
130,540.00
+2.63%
|
127,191.00
+21.51%
|
104,674.00
+51.57%
|
69,062.00
|
| Net Non Operating Interest Income Expense |
|
-3,179.00
-3393.41%
|
-91.00
-127.58%
|
330.00
+203.13%
|
-320.00
|
| Interest Expense Non Operating |
|
4,207.00
+156.52%
|
1,640.00
+202.58%
|
542.00
+43.39%
|
378.00
|
| Net Interest Income |
|
-3,179.00
-3393.41%
|
-91.00
-127.58%
|
330.00
+203.13%
|
-320.00
|
| Interest Expense |
|
4,207.00
+156.52%
|
1,640.00
+202.58%
|
542.00
+43.39%
|
378.00
|
| Interest Income Non Operating |
|
1,269.00
-30.96%
|
1,838.00
+71.94%
|
1,069.00
+347.28%
|
239.00
|
| Interest Income |
|
1,269.00
-30.96%
|
1,838.00
+71.94%
|
1,069.00
+347.28%
|
239.00
|
| Other Income Expense |
|
6,061.00
+673.42%
|
-1,057.00
-159.72%
|
1,770.00
+132.61%
|
-5,427.00
|
| Gain On Sale Of Security |
|
6,078.00
+684.42%
|
-1,040.00
-161.57%
|
1,689.00
+132.25%
|
-5,238.00
|
| Tax Provision |
|
28,106.00
+7.26%
|
26,203.00
+24.83%
|
20,991.00
+55.06%
|
13,537.00
|
| Tax Rate For Calcs |
|
0.00
+4.51%
|
0.00
+2.49%
|
0.00
+2.55%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1,308.63
+710.78%
|
-214.25
-163.11%
|
339.49
+133.07%
|
-1,026.65
|
| Net Income Including Noncontrolling Interests |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Net Income From Continuing And Discontinued Operation |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Net Income Continuous Operations |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Normalized Income |
|
97,664.63
-4.08%
|
101,813.75
+23.66%
|
82,333.49
+37.83%
|
59,736.35
|
| Net Income Common Stockholders |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Diluted EPS |
|
23.03
+1.77%
|
22.63
+21.54%
|
18.62
+52.37%
|
12.22
|
| Basic EPS |
|
23.06
+1.72%
|
22.67
+21.42%
|
18.67
+52.28%
|
12.26
|
| Basic Average Shares |
|
4,443.00
-0.24%
|
4,453.90
-0.64%
|
4,482.80
-1.06%
|
4,530.60
|
| Diluted Average Shares |
|
4,447.70
-0.34%
|
4,463.00
-0.71%
|
4,494.80
-1.10%
|
4,544.60
|
| Diluted NI Availto Com Stockholders |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Earnings From Equity Interest |
|
-17.00
+0.00%
|
-17.00
-120.99%
|
81.00
+142.86%
|
-189.00
|
| Total Other Finance Cost |
|
241.00
-16.61%
|
289.00
+46.70%
|
197.00
+8.84%
|
181.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
542,902.00
+16.60%
|
465,630.00
+48.06%
|
314,486.00
+30.35%
|
241,257.00
|
| Current Assets |
|
172,453.00
+6.59%
|
161,788.00
+15.86%
|
139,646.00
+29.07%
|
108,194.00
|
| Cash Cash Equivalents And Short Term Investments |
|
26,962.00
+2.49%
|
26,308.00
-12.97%
|
30,230.00
+28.23%
|
23,574.00
|
| Cash And Cash Equivalents |
|
26,464.00
+69.05%
|
15,655.00
+8.78%
|
14,392.00
+13.74%
|
12,653.00
|
| Cash Financial |
|
26,464.00
+69.05%
|
15,655.00
+8.78%
|
14,392.00
+13.74%
|
12,653.00
|
| Other Short Term Investments |
|
498.00
-95.33%
|
10,653.00
-32.74%
|
15,838.00
+45.02%
|
10,921.00
|
| Receivables |
|
89,186.00
+1.00%
|
88,305.00
+17.33%
|
75,261.00
+30.88%
|
57,505.00
|
| Accounts Receivable |
|
70,856.00
-1.52%
|
71,949.00
+11.08%
|
64,770.00
+28.11%
|
50,560.00
|
| Gross Accounts Receivable |
|
72,843.00
-1.66%
|
74,076.00
+11.29%
|
66,564.00
+27.81%
|
52,080.00
|
| Allowance For Doubtful Accounts Receivable |
|
-1,987.00
+6.58%
|
-2,127.00
-18.56%
|
-1,794.00
-18.03%
|
-1,520.00
|
| Other Receivables |
|
13,482.00
-0.16%
|
13,503.00
+67.36%
|
8,068.00
+34.35%
|
6,005.00
|
| Taxes Receivable |
|
4,848.00
+69.93%
|
2,853.00
+17.75%
|
2,423.00
+157.77%
|
940.00
|
| Inventory |
|
49,623.00
+21.48%
|
40,849.00
+28.41%
|
31,811.00
+30.44%
|
24,388.00
|
| Raw Materials |
|
17,436.00
+30.42%
|
13,369.00
+40.73%
|
9,500.00
+48.62%
|
6,392.00
|
| Work In Process |
|
25,858.00
+15.77%
|
22,335.00
+26.90%
|
17,601.00
+28.73%
|
13,673.00
|
| Finished Goods |
|
11,990.00
+35.13%
|
8,873.00
+22.83%
|
7,224.00
+19.64%
|
6,038.00
|
| Hedging Assets Current |
|
6,682.00
+5.63%
|
6,326.00
+169.88%
|
2,344.00
-14.04%
|
2,727.00
|
| Total Non Current Assets |
|
370,449.00
+21.92%
|
303,842.00
+73.78%
|
174,840.00
+31.40%
|
133,063.00
|
| Net PPE |
|
208,378.00
+28.88%
|
161,680.00
+77.75%
|
90,961.00
+36.43%
|
66,671.00
|
| Gross PPE |
|
267,314.00
+24.87%
|
214,076.00
+54.47%
|
138,583.00
+24.37%
|
111,426.00
|
| Accumulated Depreciation |
|
-58,936.00
-12.48%
|
-52,396.00
-10.02%
|
-47,622.00
-6.41%
|
-44,755.00
|
| Properties |
|
65,559.00
+6.82%
|
61,374.00
+25.28%
|
48,990.00
+12.87%
|
43,403.00
|
| Machinery Furniture Equipment |
|
60,020.00
+5.23%
|
57,039.00
+39.29%
|
40,951.00
+9.06%
|
37,548.00
|
| Construction In Progress |
|
130,622.00
+52.78%
|
85,497.00
+115.56%
|
39,663.00
+77.38%
|
22,361.00
|
| Other Properties |
|
11,113.00
+9.32%
|
10,166.00
+13.22%
|
8,979.00
+10.66%
|
8,114.00
|
| Goodwill And Other Intangible Assets |
|
130,053.00
+17.35%
|
110,821.00
+83.46%
|
60,406.00
+18.58%
|
50,939.00
|
| Goodwill |
|
19,845.00
-0.86%
|
20,017.00
+348.41%
|
4,464.00
-3.27%
|
4,615.00
|
| Other Intangible Assets |
|
110,208.00
+21.37%
|
90,804.00
+62.32%
|
55,942.00
+20.76%
|
46,324.00
|
| Investments And Advances |
|
2,507.00
-6.35%
|
2,677.00
+60.97%
|
1,663.00
+23.83%
|
1,343.00
|
| Long Term Equity Investment |
|
366.00
-8.50%
|
400.00
-2.44%
|
410.00
+25.38%
|
327.00
|
| Non Current Accounts Receivable |
|
5,864.00
+46.02%
|
4,016.00
+180.84%
|
1,430.00
+594.17%
|
206.00
|
| Non Current Deferred Assets |
|
23,647.00
-4.06%
|
24,648.00
+20.94%
|
20,380.00
+46.58%
|
13,904.00
|
| Non Current Deferred Taxes Assets |
|
23,647.00
-4.06%
|
24,648.00
+20.94%
|
20,380.00
+46.58%
|
13,904.00
|
| Total Liabilities Net Minority Interest |
|
348,855.00
+8.29%
|
322,144.00
+54.93%
|
207,925.00
+31.79%
|
157,771.00
|
| Current Liabilities |
|
215,661.00
-0.90%
|
217,614.00
+28.27%
|
169,655.00
+40.28%
|
120,940.00
|
| Payables And Accrued Expenses |
|
161,523.00
+0.13%
|
161,309.00
+392.97%
|
32,722.00
+44.29%
|
22,678.00
|
| Payables |
|
161,523.00
+0.13%
|
161,309.00
+392.97%
|
32,722.00
+44.29%
|
22,678.00
|
| Accounts Payable |
|
153,107.00
+1.00%
|
151,593.00
+492.02%
|
25,606.00
+64.28%
|
15,587.00
|
| Employee Benefits |
|
861.00
-4.65%
|
903.00
+21.70%
|
742.00
-2.62%
|
762.00
|
| Total Tax Payable |
|
8,416.00
-13.38%
|
9,716.00
+36.54%
|
7,116.00
+0.35%
|
7,091.00
|
| Current Debt And Capital Lease Obligation |
|
12,017.00
-8.36%
|
13,113.00
+102.42%
|
6,478.00
+341.88%
|
1,466.00
|
| Current Debt |
|
10,681.00
-9.29%
|
11,775.00
+122.00%
|
5,304.00
+1005.00%
|
480.00
|
| Other Current Borrowings |
|
9,753.00
+63.01%
|
5,983.00
+23.41%
|
4,848.00
|
—
|
| Current Capital Lease Obligation |
|
1,336.00
-0.15%
|
1,338.00
+13.97%
|
1,174.00
+19.07%
|
986.00
|
| Other Current Liabilities |
|
41,747.00
-2.69%
|
42,903.00
+43.12%
|
29,977.00
+13.08%
|
26,509.00
|
| Total Non Current Liabilities Net Minority Interest |
|
133,194.00
+27.42%
|
104,530.00
+173.14%
|
38,270.00
+3.91%
|
36,831.00
|
| Long Term Debt And Capital Lease Obligation |
|
118,941.00
+32.64%
|
89,674.00
+336.84%
|
20,528.00
-15.59%
|
24,318.00
|
| Long Term Debt |
|
111,705.00
+32.59%
|
84,246.00
+427.33%
|
15,976.00
-23.10%
|
20,775.00
|
| Long Term Capital Lease Obligation |
|
7,236.00
+33.31%
|
5,428.00
+19.24%
|
4,552.00
+28.48%
|
3,543.00
|
| Long Term Provisions |
|
5,730.00
-17.93%
|
6,982.00
+5.01%
|
6,649.00
+44.86%
|
4,590.00
|
| Non Current Pension And Other Postretirement Benefit Plans |
|
861.00
-4.65%
|
903.00
+21.70%
|
742.00
-2.62%
|
762.00
|
| Tradeand Other Payables Non Current |
|
1,051.00
-27.82%
|
1,456.00
+670.37%
|
189.00
+89.00%
|
100.00
|
| Non Current Deferred Liabilities |
|
6,611.00
+19.87%
|
5,515.00
-45.73%
|
10,162.00
+43.92%
|
7,061.00
|
| Non Current Deferred Taxes Liabilities |
|
6,611.00
+19.87%
|
5,515.00
-45.73%
|
10,162.00
+43.92%
|
7,061.00
|
| Other Non Current Liabilities |
|
—
|
23.00
-87.83%
|
189.00
+89.00%
|
100.00
|
| Stockholders Equity |
|
194,047.00
+35.24%
|
143,486.00
+34.65%
|
106,561.00
+27.64%
|
83,486.00
|
| Common Stock Equity |
|
194,047.00
+35.24%
|
143,486.00
+34.65%
|
106,561.00
+27.64%
|
83,486.00
|
| Capital Stock |
|
446.00
+0.00%
|
446.00
-1.11%
|
451.00
-1.10%
|
456.00
|
| Common Stock |
|
446.00
+0.00%
|
446.00
-1.11%
|
451.00
-1.10%
|
456.00
|
| Share Issued |
|
4,465.00
+0.00%
|
4,465.00
-1.00%
|
4,510.00
-1.10%
|
4,560.00
|
| Ordinary Shares Number |
|
4,443.48
+0.05%
|
4,441.34
-0.38%
|
4,458.29
-0.92%
|
4,499.80
|
| Treasury Shares Number |
|
21.52
-9.04%
|
23.66
-54.25%
|
51.71
-14.10%
|
60.20
|
| Retained Earnings |
|
195,298.00
+35.20%
|
144,448.00
+37.78%
|
104,839.00
+30.09%
|
80,587.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-1,695.00
-20.55%
|
-1,406.00
-210.19%
|
1,276.00
-47.90%
|
2,449.00
|
| Treasury Stock |
|
2.00
+0.00%
|
2.00
-60.00%
|
5.00
-16.67%
|
6.00
|
| Other Equity Adjustments |
|
-1,695.00
-20.55%
|
-1,406.00
-210.19%
|
1,276.00
-47.90%
|
2,449.00
|
| Total Equity Gross Minority Interest |
|
194,047.00
+35.24%
|
143,486.00
+34.65%
|
106,561.00
+27.64%
|
83,486.00
|
| Total Capitalization |
|
305,752.00
+34.26%
|
227,732.00
+85.85%
|
122,537.00
+17.53%
|
104,261.00
|
| Working Capital |
|
-43,208.00
+22.60%
|
-55,826.00
-86.03%
|
-30,009.00
-135.44%
|
-12,746.00
|
| Invested Capital |
|
316,433.00
+32.12%
|
239,507.00
+87.35%
|
127,841.00
+22.05%
|
104,741.00
|
| Total Debt |
|
130,958.00
+27.41%
|
102,787.00
+280.61%
|
27,006.00
+4.74%
|
25,784.00
|
| Net Debt |
|
95,922.00
+19.36%
|
80,366.00
+1066.75%
|
6,888.00
-19.93%
|
8,602.00
|
| Capital Lease Obligations |
|
8,572.00
+26.69%
|
6,766.00
+18.16%
|
5,726.00
+26.43%
|
4,529.00
|
| Net Tangible Assets |
|
63,994.00
+95.91%
|
32,665.00
-29.23%
|
46,155.00
+41.81%
|
32,547.00
|
| Tangible Book Value |
|
63,994.00
+95.91%
|
32,665.00
-29.23%
|
46,155.00
+41.81%
|
32,547.00
|
| Available For Sale Securities |
|
2,141.00
-5.97%
|
2,277.00
+81.72%
|
1,253.00
+23.33%
|
1,016.00
|
| Commercial Paper |
|
745.00
-86.06%
|
5,343.00
|
0.00
|
—
|
| Current Notes Payable |
|
—
|
—
|
—
|
0.00
|
| Current Provisions |
|
374.00
+29.41%
|
289.00
-99.71%
|
100,478.00
+42.95%
|
70,287.00
|
| Inventories Adjustments Allowances |
|
-5,661.00
-51.85%
|
-3,728.00
-48.29%
|
-2,514.00
-46.59%
|
-1,715.00
|
| Investmentin Financial Assets |
|
2,141.00
-5.97%
|
2,277.00
+81.72%
|
1,253.00
+23.33%
|
1,016.00
|
| Investmentsin Associatesat Cost |
|
366.00
-8.50%
|
400.00
-2.44%
|
410.00
+25.38%
|
327.00
|
| Line Of Credit |
|
183.00
-59.24%
|
449.00
-1.54%
|
456.00
-5.00%
|
480.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
119,102.00
-1.54%
|
120,968.00
+11.07%
|
108,908.00
+38.06%
|
78,887.00
|
| Cash Flow From Continuing Operating Activities |
|
119,102.00
-1.54%
|
120,968.00
+11.07%
|
108,908.00
+38.06%
|
78,887.00
|
| Net Income From Continuing Operations |
|
102,434.00
+1.43%
|
100,988.00
+20.68%
|
83,683.00
+50.71%
|
55,525.00
|
| Depreciation Amortization Depletion |
|
21,982.00
+15.05%
|
19,107.00
+102.99%
|
9,413.00
+27.86%
|
7,362.00
|
| Depreciation |
|
21,982.00
+15.05%
|
19,107.00
+102.99%
|
9,413.00
+27.86%
|
7,362.00
|
| Amortization Cash Flow |
|
—
|
2,512.00
|
—
|
1,599.00
|
| Depreciation And Amortization |
|
21,982.00
+15.05%
|
19,107.00
+102.99%
|
9,413.00
+27.86%
|
7,362.00
|
| Amortization Of Intangibles |
|
—
|
2,512.00
|
—
|
1,599.00
|
| Other Non Cash Items |
|
-3,122.00
-801.57%
|
445.00
+4.95%
|
424.00
-82.09%
|
2,367.00
|
| Pension And Employee Benefit Expense |
|
—
|
-119.00
-100.37%
|
32,243.00
+5142.76%
|
615.00
|
| Stock Based Compensation |
|
—
|
2,289.00
+6.51%
|
2,149.00
+39.64%
|
1,539.00
|
| Provisionand Write Offof Assets |
|
—
|
21,030.00
-34.75%
|
32,230.00
+74.55%
|
18,465.00
|
| Asset Impairment Charge |
|
—
|
10,562.00
|
—
|
809.00
|
| Deferred Tax |
|
28,106.00
+7.26%
|
26,203.00
+24.83%
|
20,991.00
+55.06%
|
13,537.00
|
| Deferred Income Tax |
|
28,106.00
+7.26%
|
26,203.00
+24.83%
|
20,991.00
+55.06%
|
13,537.00
|
| Operating Gains Losses |
|
—
|
-11,027.00
-134.17%
|
32,268.00
+23282.61%
|
138.00
|
| Gain Loss On Investment Securities |
|
—
|
-5,079.00
-4891.51%
|
106.00
-95.88%
|
2,572.00
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
-5,846.00
-356.74%
|
2,277.00
+170.32%
|
-3,238.00
|
| Change In Working Capital |
|
3,737.00
+44.34%
|
2,589.00
-86.87%
|
19,713.00
+456.15%
|
-5,535.00
|
| Change In Receivables |
|
—
|
-14,309.00
+12.07%
|
-16,273.00
-50.34%
|
-10,824.00
|
| Changes In Account Receivables |
|
—
|
-7,179.00
+49.48%
|
-14,210.00
-43.29%
|
-9,917.00
|
| Change In Inventory |
|
—
|
-9,038.00
-21.76%
|
-7,423.00
-55.72%
|
-4,767.00
|
| Change In Payables And Accrued Expense |
|
—
|
-280.00
-103.69%
|
7,587.00
+47.32%
|
5,150.00
|
| Change In Payable |
|
—
|
-280.00
-103.69%
|
7,587.00
+47.32%
|
5,150.00
|
| Change In Account Payable |
|
—
|
3,240.00
-67.66%
|
10,019.00
+49.16%
|
6,717.00
|
| Change In Other Working Capital |
|
—
|
2,510.00
+303.24%
|
-1,235.00
-206.47%
|
1,160.00
|
| Change In Other Current Liabilities |
|
—
|
9,122.00
+78.90%
|
5,099.00
+36.12%
|
3,746.00
|
| Investing Cash Flow |
|
-79,158.00
+38.59%
|
-128,895.00
-193.66%
|
-43,892.00
-76.15%
|
-24,918.00
|
| Cash Flow From Continuing Investing Activities |
|
-79,158.00
+38.59%
|
-128,895.00
-193.66%
|
-43,892.00
-76.15%
|
-24,918.00
|
| Net PPE Purchase And Sale |
|
-60,140.00
-27.51%
|
-47,164.00
-82.76%
|
-25,806.00
-112.47%
|
-12,146.00
|
| Purchase Of PPE |
|
-60,140.00
-27.51%
|
-47,164.00
-82.76%
|
-25,806.00
-112.47%
|
-12,146.00
|
| Sale Of PPE |
|
—
|
—
|
—
|
0.00
|
| Capital Expenditure |
|
-90,113.00
-75.63%
|
-51,309.00
-31.91%
|
-38,896.00
-163.65%
|
-14,753.00
|
| Net Investment Purchase And Sale |
|
9,951.00
+117.41%
|
4,577.00
+191.61%
|
-4,996.00
-61.68%
|
-3,090.00
|
| Purchase Of Investment |
|
-723.00
+96.35%
|
-19,814.00
-49.10%
|
-13,289.00
-36.51%
|
-9,735.00
|
| Sale Of Investment |
|
10,674.00
-56.24%
|
24,391.00
+194.12%
|
8,293.00
+24.80%
|
6,645.00
|
| Net Business Purchase And Sale |
|
1,004.00
+101.22%
|
-82,163.00
|
0.00
+100.00%
|
-7,075.00
|
| Purchase Of Business |
|
0.00
+100.00%
|
-82,163.00
|
0.00
+100.00%
|
-7,075.00
|
| Net Intangibles Purchase And Sale |
|
-29,973.00
-623.11%
|
-4,145.00
+68.33%
|
-13,090.00
-402.11%
|
-2,607.00
|
| Purchase Of Intangibles |
|
-29,973.00
-623.11%
|
-4,145.00
+68.33%
|
-13,090.00
-402.11%
|
-2,607.00
|
| Financing Cash Flow |
|
-28,408.00
-425.22%
|
8,735.00
+113.83%
|
-63,158.00
-21.93%
|
-51,797.00
|
| Cash Flow From Continuing Financing Activities |
|
-28,408.00
-425.22%
|
8,735.00
+113.83%
|
-63,158.00
-21.93%
|
-51,797.00
|
| Net Issuance Payments Of Debt |
|
24,743.00
-66.13%
|
73,056.00
+5079.96%
|
-1,467.00
+39.08%
|
-2,408.00
|
| Issuance Of Debt |
|
103,931.00
+30.91%
|
79,391.00
|
0.00
-100.00%
|
11,215.00
|
| Repayment Of Debt |
|
-79,188.00
-1150.01%
|
-6,335.00
-331.83%
|
-1,467.00
+89.23%
|
-13,623.00
|
| Long Term Debt Issuance |
|
103,931.00
+30.91%
|
79,391.00
|
0.00
-100.00%
|
11,215.00
|
| Long Term Debt Payments |
|
-79,188.00
-1150.01%
|
-6,335.00
-331.83%
|
-1,467.00
+89.23%
|
-13,623.00
|
| Net Long Term Debt Issuance |
|
24,743.00
-66.13%
|
73,056.00
+5079.96%
|
-1,467.00
+39.08%
|
-2,408.00
|
| Net Common Stock Issuance |
|
-1,388.00
+93.12%
|
-20,181.00
+32.56%
|
-29,924.00
-24.24%
|
-24,086.00
|
| Common Stock Payments |
|
-1,388.00
+93.12%
|
-20,181.00
+32.56%
|
-29,924.00
-24.24%
|
-24,086.00
|
| Cash Dividends Paid |
|
-51,763.00
-17.27%
|
-44,140.00
-38.95%
|
-31,767.00
-25.55%
|
-25,303.00
|
| Repurchase Of Capital Stock |
|
-1,388.00
+93.12%
|
-20,181.00
+32.56%
|
-29,924.00
-24.24%
|
-24,086.00
|
| Changes In Cash |
|
11,536.00
+1327.72%
|
808.00
-56.51%
|
1,858.00
-14.46%
|
2,172.00
|
| Effect Of Exchange Rate Changes |
|
-727.00
-259.78%
|
455.00
+482.35%
|
-119.00
+50.00%
|
-238.00
|
| Beginning Cash Position |
|
15,655.00
+8.78%
|
14,392.00
+13.74%
|
12,653.00
+18.04%
|
10,719.00
|
| End Cash Position |
|
26,464.00
+69.05%
|
15,655.00
+8.78%
|
14,392.00
+13.74%
|
12,653.00
|
| Free Cash Flow |
|
28,989.00
-58.38%
|
69,659.00
-0.50%
|
70,012.00
+9.17%
|
64,134.00
|
| Dividends Received CFI |
|
—
|
—
|
0.00
|
0.00
|
| Earnings Losses From Equity Investments |
|
—
|
17.00
+120.99%
|
-81.00
-142.86%
|
189.00
|
| Interest Paid CFO |
|
-3,419.00
-458.66%
|
-612.00
-24.64%
|
-491.00
-80.51%
|
-272.00
|
| Interest Received CFO |
|
1,398.00
-25.80%
|
1,884.00
+75.75%
|
1,072.00
+288.41%
|
276.00
|
| Sale Of Business |
|
1,004.00
|
0.00
|
0.00
|
—
|
| Taxes Refund Paid |
|
-32,014.00
-8.02%
|
-29,636.00
-14.44%
|
-25,897.00
-78.42%
|
-14,515.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|